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Introduction: We tested two hypotheses that disseminated intravascular coagulation (DIC) and acute coagulopathy
of trauma-shock (ACOTS) in the early phase of trauma are similar disease entities and that the DIC score on
admission can be used to predict the prognosis of patients with coagulopathy of trauma.
Methods: We conducted a retrospective study of 562 trauma patients, including 338 patients whose data were
obtained immediately after admission to the emergency department. We collected serial data for the platelet
counts, global markers of coagulation and fibrinolysis, and antithrombin levels. DIC was diagnosed according
to the Japanese Association for Acute Medicine (JAAM) DIC scoring system, and ACOTS was defined as a
prothrombin-time ratio of >1.2.
Results: The higher levels of fibrin/fibrinogen degradation products (FDP) and D-dimer and greater FDP/D-dimer
ratios in the DIC patients suggested DIC with the fibrinolytic phenotype. The DIC patients with the fibrinolytic
phenotype exhibited persistently lower platelet counts and fibrinogen levels, increased prothrombin time ratios,
higher FDP and D-dimer levels, and lower antithrombin levels compared with the non-DIC patients on arrival to
the emergency department and during the early stage of trauma. Almost all ACOTS patients met the criteria for a
diagnosis of DIC; therefore, the same changes were observed in the platelet counts, global markers of coagulation
and fibrinolysis, and antithrombin levels as noted in the DIC patients. The JAAM DIC score obtained immediately
after arrival to the emergency department was an independent predictor of massive transfusion and death due to
trauma and correlated with the amount of blood transfused.
Conclusions: Patients who develop DIC with the fibrinolytic phenotype during the early stage of trauma exhibit
consumption coagulopathy associated with increased fibrin(ogen)olysis and lower levels of antithrombin. The
same is true in patients with ACOTS. The JAAM DIC score can be used to predict the prognosis of patients with
coagulopathy of trauma.Introduction
The coagulopathy of trauma is a syndrome characterized
by a nonsurgical oozing-type of bleeding from mucosal
regions, serosal surfaces and wounds, and vascular-access
sites that is distinct from simple massive bleeding and is
caused by multiple factors, such as hypothermia, acidosis,
hemodilution, hemorrhagic shock, and serious trauma
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stated.induced disseminated intravascular coagulation (DIC)
with the fibrinolytic phenotype has been believed to be
the primary cause of coagulopathy of trauma [1,2]. Persist-
ently lower platelet counts and fibrinogen levels, more-
prolonged prothrombin times, increased fibrinogen and
fibrin degradation product (FDP) levels, and low levels of
proteins that control coagulation (antithrombin) and fibri-
nolysis (α2-plasmin inhibitor) have been repeatedly con-
firmed in DIC patients during the early to late phases of
trauma, irrespective of the use of massive platelet concen-
trate and fresh frozen plasma (FFP) transfusions [2,3].
Two decades after the discovery of trauma- and shock-
induced DIC, Brohi et al. [4] and MacLoad et al. [5]Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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lopathy of trauma [2]. Based on this discovery, another
concept of coagulopathy of trauma called acute coagu-
lopathy of trauma-shock (ACOTS) was established as a
distinct disease entity distinct from DIC [6,7]. In this con-
cept, ACOTS, not DIC, is considered to be the primary
pathophysiological mechanism of coagulopathy of trauma.
The authors asserted that no evidence implicates the
process of DIC in the development of coagulopathy of
trauma [6-8]. Legitimate rebuttals of these concepts have
reviewed the similarities and differences in DIC and
ACOTS and reconfirmed the appropriateness of the DIC
concept [9,10]. Until recently, almost all studies on ACOTS
have discussed its pathophysiology based on single-point
sampling of blood or single-point measurement of the
parameters of viscoelastic devices [9,10]. Therefore, data
regarding serial changes in the platelet counts and global
markers of coagulation and fibrinolysis in patients with
ACOTS are lacking.
In the present study, to test the hypothesis that similar-
ities exist between DIC with the fibrinolytic phenotype
and ACOTS, we measured platelet counts, global markers
of coagulation and fibrinolysis, and antithrombin levels in
trauma patients immediately after arrival to the emer-
gency department and during the early phase of trauma.
Another hypothesis was that DIC diagnostic criteria con-
sisting of various markers of coagulation and fibrinolysis
can be used to predict the prognosis of trauma patients
with coagulopathy of trauma.
Recently, coagulopathy of trauma has been termed
trauma-induced coagulopathy, whereas the term ACOTS
has been replaced with acute traumatic coagulopathy.
However, the present study uses the original terminology,
coagulopathy of trauma and ACOTS as a representative
nomenclature for the various terminologies derived from
ACOTS without a clear definition.
Materials and methods
Patient selection and data collection
This retrospective study was conducted at three tertiary
critical care centers with the approval of the institutional
review board of each hospital (Institutional Review Board
of Hokkaido University Hospital for Clinical Research;
Ethics Committee of Sapporo City General Hospital; and
Ethics Committee of Teine Keijinkai Hospital). The need
for informed consent was waived because of the anonym-
ous, observational, and retrospective nature of the study.
Severe trauma patients, defined as Injury Severity Score
(ISS) ≥9 (at least one abbreviated injury scale ≥3), were
enrolled in the study. Trauma patients with cardiac arrest
or those resuscitated from cardiac arrest, as well as
individuals receiving anticoagulant therapy and those
having known clotting disorders, such as hematopoietic
malignancies or severe liver cirrhosis, were excluded. Asystematic review of the computer-based medical records
of these patients was retrospectively conducted to obtain
baseline characteristics, levels of coagulation and fibrino-
lytic markers, and DIC-related variables. The data for
these variables were obtained on day 0 (on admission) and
on days 1 and 2. Patient data that could be collected im-
mediately on arrival to the emergency department were
obtained at four time points within 24 hours after arrival:
time point 0, immediately after arrival at the emergency
department; time point 1, 4 to 8 hours after arrival; time
point 2, 8 to 16 hours after arrival; and time point 3, 16 to
24 hours after arrival.
Definitions and diagnosis
The severity of illness was evaluated according to the Acute
Physiology and Chronic Health Evaluation (APACHE) II
score within 24 hours after the admission [11]. Organ fail-
ure was assessed by using the Sequential Organ Failure
Assessment (SOFA) score [12]. The systemic inflammatory
response syndrome (SIRS) was defined according to criteria
of the American College of Chest Physicians/Society of
Critical Care Medicine consensus conference [13]. Multiple
organ dysfunction syndrome (MODS) was defined as a
SOFA score ≥12 [12]. Massive bleeding (requiring
transfusion) was defined as the total amount of packed
red blood cells (PRBCs) and FFP ≥2,000 ml (approxi-
mately 50% of the circulating blood volume of an average
Japanese individual) transfused for 24 hours from the time
of initial presentation to the emergency department. DIC
diagnosis was made based on the Japanese Association for
Acute Medicine (JAAM) DIC diagnosis criteria [14]. The
overt DIC score, determined according to the Inter-
national Society on Thrombosis and Haemostasis (ISTH),
was also calculated [15]. The FDP level was used as the
fibrin-related marker in the ISTH criteria. No increase,
moderate increase, and strong increase were defined as an
FDP level of <9, 10 to 24, and >25 mg/L, respectively. The
DIC scores were calculated by using laboratory tests per-
formed at the same time points. When the total score
was ≥4 and ≥5, the JAAM and ISTH overt DIC diagnosis
was established, respectively. Patients who did not undergo
all of the required laboratory tests were diagnosed as having
JAAM and ISTH overt DIC if the sum of the available data
was ≥4 and ≥5.
In the present study, ISTH DIC was defined as that
the JAAM DIC patients simultaneously met the ISTH
overt DIC criteria. ACOTS was defined as a prothrom-
bin time ratio of >1.2 based on the announcement that a
prothrombin time ratio of >1.2 should be adopted as the
clinically relevant definition of ACOTS by the multi-
national ACOTS group [16]. This group declared this def-
inition as appropriate for future use and indicated that
they expect the use of this definition to increase signifi-
cantly the reported incidence of ACOTS. The outcome
Table 1 Baseline characteristics of all 562 patients
included in the study
Non-DIC JAAM DIC P value




Age (years) 48 ± 20 49 ± 23 49 ± 25 0.682
Sex (male/female) 64/193 76/134 43/52 0.001
Injury Severity Score 20.7 ± 11.5 25.7 ± 13.0 35.3 ± 13.0 0.000
APACHE II score 13.9 ± 7.2 19.7 ± 8.2 26.1 ± 8.1 0.000
SOFA score 5.0 ± 2.2 6.5 ± 3.3 10.2 ± 3.6 0.000
SIRS criteria 2.8 ± 0.8 3.4 ± 0.7 3.0 ± 0.9 0.000
JAAM DIC score (day 0) 1.5 ± 1.0 4.7 ± 1.0 6.7 ± 1.3 0.000
ISTH DIC score (day 0) 1.2 ± 1.2 3.3 ± 0.6 5.9 ± 1.0 0.000
MODS (yes/no) 2/255 22/188 41/54 0.000
Outcome (survived/died) 248/9 174/36 54/41 0.000
FDP/D-dimer ratio 1.6 ± 0.9 1.8 ± 0.7 4.3 ± 19.8 0.000
Lactate (mM) 3.2 ± 1.9 4.9 ± 3.2 8.2 ± 5.1 0.000
APACHE, Acute Physiology and Chronic Health Evaluation; DIC, disseminated
intravascular coagulation; FDP, fibrin fibrinogen degradation products;
FFP, fresh frozen plasma; ISTH, International Society on Thrombosis and
Haemostasis; JAAM, Japanese Association for Acute Medicine; MODS, multiple
organ dysfunction syndrome; PRBCs, packed red blood cells; SIRS, systemic
inflammatory response syndrome; SOFA, Sequential Organ Failure Assessment.
ISTH (−) (+), JAAM DIC patients who did not meet the ISTH overt DIC criteria
and those who simultaneously met the ISTH overt DIC criteria, respectively.
P value, Kruskal-Wallis test.
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in the emergency department.
Measurement methods and treatment
Prospective blood sampling was performed on admission
to the emergency department and daily thereafter, as
part of a routine clinical and laboratory workup using
established standard laboratory techniques at each hos-
pital. Platelet count, prothrombin time ratio, and the levels
of fibrinogen, FDP, D-dimer, and antithrombin were
collected. The platelet counts (XE-5000; Sysmex, Tokyo,
Japan), and levels of fibrinogen (Thrombocheck Fib; Sys-
mex), FDP (NanopiaP-FDP, Sekisuimedical, Tokyo), and
D-dimer (Nanopia D-dimer; Sekisuimedical) were mea-
sured by using the same kits in three hospitals. The pro-
thrombin time (Tromborel S; Siemens, and CoagpiaN,
Sekisuimedical) and antithrombin levels (Testtime ATIII,
Sekisuimedical; Lsystem ATIII, Sysmex; Antithrombin S,
Siemens) were measured by using different kits in three
hospitals. In addition, blood-gas analyses were used for
lactate measurement. Treatment selection was at the dis-
cretion of each critical care center; however, standard
strategies for treating trauma were applied based on the
Japan Advanced Trauma Evaluation and Care guidelines
established by the Japanese Association for the Surgery of
Trauma.
Statistical analysis
All data are expressed as the mean ± standard deviation.
The IBM SPSS 21.0 for MAC OSX software package (IBM
Japan, Tokyo) was used for all statistical-calculation ana-
lyses. Comparisons between the two groups were made by
using the Mann–Whitney U test and either the χ2 test or
Fisher Exact test if necessary. To compare three groups, the
Kruskal-Wallis test was applied. The relations between the
measured variables and mortality or massive bleeding were
analyzed by stepwise logistic regression analysis (the back-
ward stepwise method based on likelihood) with the use of
death or massive bleeding as dependent variables. The re-
sults were reported as the odds ratios and 95% confidence
intervals (CIs). A multiple regression with stepwise method
was applied to predict the amount of transfusion. A value
of P < 0.05 was considered to be statistically significant.
Results
Baseline patient characteristics
In total, 562 patients were included in the present study.
The baseline characteristics of these patients are presented
in Table 1. The JAAM DIC patients, especially those who
simultaneously met the ISTH overt DIC criteria, had more
serious injuries and higher APACHE II and SOFA scores,
therefore exhibiting poor outcomes associated with MODS.
These results demonstrated that the prognosis of the
trauma patients deteriorated in accordance with increasingabnormalities of coagulation and fibrinolysis (that is, the
severity of DIC). Higher FDP and D-dimer levels as well as
greater FDP/D-dimer ratios in the DIC patients were ob-
served as a result of increased fibrin(ogen)olysis, suggesting
the presence of DIC with the fibrinolytic phenotype.
Of the 562 patients, the data for 338 patients were
collected immediately after admission to the emergency
department. The baseline characteristics of these patients
are presented in Table 2. In addition to having the same
characteristics as the DIC patients shown in Table 1, the
DIC patients received higher levels of transfused platelet
concentrate, PRBCs, and FFP than the non-DIC patients
within 24 hours after arrival to the emergency department.
As a result, the DIC patients frequently met the criteria
for a massive transfusion.
We found that 174 of the total 562 patients and 123 of
the 338 patients met the criteria for ACOTS. The base-
line characteristics of the ACOTS patients are presented
in Table 3, which shows that the patients exhibited
similarities to the characteristics of DIC. Almost all of the
ACOTS patients whose data were obtained immediately
after arrival in the emergency department were diagnosed
as having JAAM DIC (104 of 123; 84.6%); however, 19 of
the 123 ACOTS patients did not fulfill the JAAM DIC cri-
teria. Figure 1 shows the relation between ACOTS (123 of
338) and JAAM DIC patients (201 of 338) diagnosed im-
mediately on admission to the emergency department.
Table 2 Baseline characteristics of the 338 patients whose data were collected immediately after arrival in the
emergency department
Non-DIC JAAM DIC P value
(n = 137) ISTH (−) (n = 131) ISTH (+) (n = 70)
Age (years) 48 ± 20 47 ± 23 47 ± 24 0.862
Sex (male/female) 40/97 46/85 32/38 0.062
Injury severity score 22.1 ± 12.1 27.9 ± 13.4 37.5 ± 12.2 0.000
APACHE II score 15.6 ± 7.5 21.6 ± 8.4 26.4 ± 8.3 0.000
SOFA score 5.6 ± 2.9 7.4 ± 3.6 10.9 ± 3.6 0.000
SIRS criteria 2.9 ± 0.9 3.3 ± 0.7 3.0 ± 0.9 0.000
JAAM DIC score 1.6 ± 0.9 4.7 ± 0.9 6.3 ± 1.3 0.000
ISTH DIC score 1.3 ± 1.2 3.2 ± 0.7 6.0 ± 0.9 0.000
MODS (yes/no) 4/133 26/105 31/39 0.000
Outcome (survived/died) 127/10 100/31 36/34 0.000
FDP/D-dimer ratio 1.8 ± 1.1 1.9 ± 0.7 5.3 ± 23.8 0.002
FFP/PRBC transfusion ratio 0.7 ± 0.4 1.0 ± 0.9 1.1 ± 0.9 0.073
Lactate (mM) 3.6 ± 2.6 4.8 ± 3.5 7.8 ± 4.9 0.000
Platelet concentrate (U) 3.4 ± 9.1 4.5 ± 10.2 23.0 ± 24.8 0.000
Packed red blood cells (ml) 247 ± 708 666 ± 1,442 2,655 ± 3,180 0.000
Fresh frozen plasma (ml) 159 ± 431 575 ± 1,101 2,275 ± 2,586 0.000
Massive transfusion (yes/no) 11/126 29/102 48/22 0.000
Abbreviations, see Table 1. P value, Kruscal-Wallis test. The JAAM and ISTH DIC scores were calculated by using the data obtained immediately after arrival in the
emergency department (time point 0 in Figure 3). The amounts of platelet concentrate, packed red blood cells, and fresh frozen plasma indicate the total amount
of volume transfused within 24 hours after the arrival in the emergency department.
Table 3 Baseline characteristics of the patients with acute








Age (years) 46 ± 23 46 ± 23 52 ± 18
Sex (male/female) 64/114 74/49 13/6
Injury Severity Score 31.0 ± 13.7 32.6 ± 13.6 20.9 ± 11.3
APACHE II score 22.5 ± 8.9 23.5 ± 8.9 19.4 ± 8.8
SOFA score 9.1 ± 3.9 9.8 ± 3.8 8.4 ± 3.0
SIRS criteria 3.1 ± 0.9 3.1 ± 0.9 3.0 ± 1.0
JAAM DIC score 5.6 ± 1.9 5.2 ± 1.8 2.1 ± 0.5
ISTH DIC score 4.6 ± 1.7 4.5 ± 1.9 1.7 ± 1.2
MODS (yes/no) 52/122 41/63 2/17
Outcome (survived/died) 122/52 75/48 16/3
Prothrombin time ratio 1.7 ± 1.1 1.7 ± 0.9 1.4 ± 0.3
Platelet concentrate (U) - 14.0 ± 21.7 5.7 ± 13.5
Packed red blood cell (ml) - 1,715 ± 2,609 382 ± 547
Fresh frozen plasma (ml) - 1,422 ± 2,074 195 ± 284
Abbreviations, see Table 1. aOf the total 562 patients, the day 0 data for 174
patients who met the ACOTS criteria are shown. bOf the 338 patients whose
data were obtained immediately after admission, 123 met the ACOTS criteria,
and their data on admission are presented. cThe data for 19 patients who met
the ACOTS criteria but not the JAAM DIC criteria are shown. Of the 123 ACOTS
patients, 19 did not meet the JAAM DIC criteria.
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coagulation and fibrinolysis
Figure 2 shows the changes in markers in all 562 pa-
tients. Consistent with the results of previous studies on
DIC after trauma, persistently lower platelet counts and
fibrinogen levels, higher prothrombin time ratios, higherDIC (N=201)
ACOTS (N=123)
N=104 N=19
Figure 1 Relations between DIC (bold circle, n = 201) and
ACOTS (open circle, n = 123). Almost all ACOTS patients (n = 104)
were included as DIC patients. Only 19 patients with ACOTS did not

































Figure 2 The bar graphs show the changes in the platelet counts, prothrombin time ratio (PT ratio), and levels of fibrinogen, FDP,
D-dimer, and antithrombin in the total 562 patients. ACOTS, patients who met the ACOTS diagnostic criteria; control, patients who did not
meet the JAAM DIC criteria; ISTH, patients who simultaneously met both the JAAM and ISTH DIC criteria; JAAM, patients who met the JAAM DIC
criteria. The ACOTS patients overlapped with control, JAAM, and ISTH patients. *P < 0.05; **P < 0.01; †P < 0.001 versus control.
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thrombin were observed in the DIC patients compared
with those observed in the non-DIC patients from day 0
to day 2 [3]. These changes were more pronounced in
the patients who simultaneously met the ISTH overt
DIC criteria. Figure 3 shows the changes in markers of
338 patients whose data were collected immediately after
arrival in the emergency department. The same time
courses were observed in the platelet counts, coagulation
and fibrinolysis markers, and antithrombin levels as
those noted in the 562 patients during the first 24 hours
after arrival in the emergency department.
Figures 2 and 3 also show the changes in the platelet
counts, global markers of coagulation and fibrinolysis, and
antithrombin levels in the patients with ACOTS. Because
of the large overlap of the patients with DIC and ACOTS,
a statistical analysis was not applied to the patients with
ACOTS. However, Figures 2 and 3 clearly demonstrate
that the changes in the platelet counts, global markers of
coagulation and fibrinolysis, and antithrombin levels in
the patients with ACOTS coincided with those of the DIC
patients. The details of the number of patients in Figures 2
and 3 are presented in Additional file 1.
Outcome prediction and need for massive transfusion
Data obtained immediately after arrival in the emergency
department are critical for predicting the prognosis ofseverely injured trauma patients with massive bleeding
and hemorrhagic shock. Therefore, the data of the 338
patients for whom data were available immediately after
admission were used to predict the prognoses of the pa-
tients in this study. Table 4 shows that both the JAAM
DIC score and the fibrinogen level on admission could
be used to predict patient death and the need for a
massive transfusion. Table 5 indicates that the amounts
of transfused platelet concentrate and PRBC and FFP
correlated strongly with the JAAM DIC score and fibri-
nogen level on admission.
Discussion
The higher levels of FDP and D-dimer and higher FDP/
D-dimer ratios observed in the present patients indicate
that the DIC diagnosed in this study was the fibrinolytic
phenotype [2,10]. Our study demonstrates that patients
who develop DIC with the fibrinolytic phenotype imme-
diately after trauma exhibit consumption coagulopathy
associated with increased fibrin(ogen)olysis and lower
levels of antithrombin [1,3]. The same findings were true
in the patients with ACOTS.
In Japan, emergency medical teams are not permitted to
infuse and/or transfuse any fluids or blood products in
trauma patients during transportation. The standard prac-
tice is to draw blood immediately after the patient arrives




























Figure 3 The bar graphs show the changes in the platelet counts, prothrombin-time ratio (PT ratio), and levels of fibrinogen, FDP,
D-dimer, and antithrombin in the 338 patients for whom data were collected immediately after admission in the emergency department.
ACOTS, patients who met the ACOTS diagnostic criteria; control, patients who did not meet the JAAM DIC criteria; ISTH, patients who
simultaneously met both the JAAM and ISTH DIC criteria; JAAM, patients who met the JAAM DIC criteria. The ACOTS patients overlapped with
the control, JAAM, and ISTH patients. For time points 0 to 3, refer to the Methods section in detail. *P < 0.05; **P < 0.01; †P < 0.001 versus control.
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Therefore, the data obtained at time point 0 in Figure 3
were not influenced by either hemodilution or hypother-
mia. A possibility exists that hemodilution could have
affected the changes in the measured parameters, espe-
cially the platelet counts and levels of fibrinogen and anti-
thrombin at time points 1 to 3. However, the guidelinesTable 4 Stepwise logistic regression analysis for
predicting death and massive transfusion in the 338
patients
Odds ratio P value 95% confidence
interval
Death
Age 1.038 0.000 1.019–1.057
Platelet counts 1.110 0.001 1.045–1.179
Prothrombin time ratio 4.718 0.007 1.529–14.557
Fibrinogen 0.990 0.021 0.982–0.999
FDP 1.005 0.001 1.002–1.007
JAAM DIC score 3.129 0.035 1.084–9.033
Massive transfusion
Fibrinogen 0.991 0.001 0.986–0.997
JAAM DIC score 4.607 0.001 1.935–10.972
Abbreviations, see Table 1. Independent variables, age, sex, platelet count,
prothrombin time ratio, fibrinogen, FDP, and JAAM DIC score on admission.for transfusion therapy and the proper use of blood prod-
ucts published by the Japanese Ministry of Health Labor
and Welfare in 2005 clearly state that complications of
consumption coagulopathy caused by DIC should always
be examined in trauma patients, and if consumption coag-
ulopathy exists, trauma specialists should consider trans-
fusing a sufficient amount of FFP [2]. The high FFP/PRBC
transfusion ratio observed in the DIC patients indicates
the application of these guidelines, which may have pre-
vented the effect of hemodilution.
The use of sampling time points is important for
assessing coagulopathy during the early stage of trauma
[9,10]. The hemostatic changes that occur after trauma
are rapidly dynamic processes; therefore, obtaining serial
measurements of multiple markers of coagulation and
fibrinolysis is essential. Almost all ACOTS studies using
only single-point sampling of blood on arrival in the
emergency department, especially those that lack a con-
trol cohort, should elicit caution when interpreting the
results with respect to hemostasis or pathologic coagu-
lopathy [9,10]. To our knowledge, this is the first study
showing that the serial changes in platelet counts, global
markers of coagulation and fibrinolysis, and antithrom-
bin levels in patients with ACOTS during the early stage of
trauma were equal to those of DIC patients. Both the
JAAM DIC and ISTH overt DIC diagnostic criteria
Table 5 Multiple regression analysis using the stepwise method for predicting the transfusion of platelet concentrate
and the total amount of packed red blood cells (PRBCs) and fresh frozen plasma (FFP)
B (SE) β P value 95% CI R2 ANOVA
Platelet concentrate 0.207 0.000
Platelet count −0.27 (0.13) −0.13 0.045 −0.524 to −0.007
Prothrombin time ratio 4.0 (1.8) 0.16 0.025 0.509 to 7.401
FDP −0.02 (0.005) −0.21 0.002 −0.024 to −0.005
JAAM DIC score 2.8 (0.5) 0.35 0.000 1.749 to 3.757
Transfusion (PRBCs and FFP) 0.169 0.000
JAAM DIC score 701 (92) 0.41 0.000 518.4 to 884.3
B, partial regression coefficient; SE, standard error; β, standard partial regression coefficient; CI, confidence interval; R2, coefficient of determination; ANOVA,
analysis of variance. Independent variables: platelet count, prothrombin time ratio, the fibrinogen level, the FDP levels, and the JAAM DIC score on admission.
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time in their scoring systems, which easily explains
the overlap between DIC and ACOTS patients ob-
served in the present study, as well as in our previous
study [17].
ACOTS is an incomprehensible disease entity with
almost the same diagnostic criteria as DIC, but a clearly
different pathophysiology. Thrombin generation increases
in the circulation in DIC patients but is inhibited by acti-
vated protein C in patients with ACOTS, which is the rea-
son for their bleeding tendency [7-10]. Liberal transfusion
of FFP-containing protein C, a source of activated protein
C, would theoretically inhibit thrombin formation and ag-
gravate ACOTS. FFP also contains anticoagulants against
thrombin, such as antithrombin and tissue-factor pathway
inhibitor, as well as coagulation factors; therefore, FFP
transfusion is recommended for DIC patients to control
thrombin generation and to treat consumption coagu-
lopathy [2,9,10]. On the contrary, the antithrombin levels
should be kept as low as possible to enhance the thrombin
formation in ACOTS patients. Therefore, FFP trans-
fusion is reasonably contraindicated in trauma pa-
tients with ACOTS if its basic principles were correct
[2,9,10,18,19].
Dunbar et al. [20,21] elegantly demonstrated marked
systemic thrombin generation caused by circulating pro-
coagulants, such as tissue factor and microparticles, and
a reduced ability to localize hemostasis at the wound site
due to the loss of antithrombin in patients with ACOTS.
The antithrombin levels in both the DIC and ACOTS
patients observed in the present and previous studies
were lower than those in the control subjects [17,18]. A
multiple regression analysis clearly indicated that a lower
antithrombin level is the major determinant of a systemic
increase in thrombin generation and activity in DIC
patients [17]. It should therefore be noted that the coagula-
tion-control pathways induced by antithrombin are
insufficient to anchor thrombin at the injured site
after trauma in patients with both DIC and ACOTS.These results obtained from multiple studies theoretically
support the use of FFP transfusion to correct consump-
tion coagulopathy in DIC patients [22] and reveal contra-
dictions in the pathophysiology of ACOTS [9,10].
By using data obtained immediately after arrival in the
emergency department and data readily available world-
wide, we analyzed the prognosis of trauma patients in
the present study. The results showed that the JAAM
DIC score and fibrinogen level on admission can be used
to predict both the need for massive transfusions within
24 hours after presentation in the emergency room and
in-hospital patient death. In addition, the FDP level was
found to be an independent predictor of patient death,
suggesting the important role of fibrin(ogen)olysis in
DIC with the fibrinolytic phenotype [23]. Multivariate
analysis suggested that the total amount of transfused
platelet concentrate, PRBC, and FFP correlated significantly
with the JAAM DIC score, platelet count, prothrombin
time ratio, and FDP level. However, the coefficients of
determination (R2) were relatively low at 0.207 for platelet
concentrate and 0.169 for PRBC and FFP (Table 5). These
results indicate that other factors are involved in de-
termining the transfusion volume during the early stage of
trauma.
Limitations
The retrospective nature of this study, missing data from
days 1 and 2 and time points 1 through 3 and the use of
different reagents and kits to measure the markers levels
between the hospitals may limit interpretation of our
results. In addition, we did not examine microvascular
fibrin thrombosis, the gold standard for the diagnosis of
“DIC with the thrombotic phenotype.” However, it has
long been recognized that demonstrating fibrin throm-
bosis is dependent on the time elapsed to autopsy and that
microvascular thrombosis in cases of DIC with the fibri-
nolytic phenotype is difficult to demonstrate and can be
observed only with the use of antifibrinolytic agents be-
cause of hyperfibrin(ogen)olysis [2,9,10,24,25].
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The majority of patients with the ACOTS clearly meet
the criteria for a diagnosis of DIC with the fibrinolytic
phenotype, including very similar sequential changes
observed in most of the relevant hemostatic markers.
This observation supports our hypothesis that ACOTS
can be considered the same disease entity as DIC of the
fibrinolytic phenotype. Furthermore, the lower anti-
thrombin levels observed in patients with ACOTS and
DIC implies a same pathophysiology as well as same
treatment indications for trauma patients with these two
different concepts of coagulopathy, which also supports
our hypothesis. Most relevantly, the JAAM DIC score
obtained in trauma patients immediately after arrival in
the emergency department can be used as an independ-
ent predictor of higher mortality risk and the need for
massive transfusion and damage-control resuscitation
Key messages
 DIC with the fibrinolytic phenotype exhibits
consumption coagulopathy associated with increased
fibrin(ogen)olysis and a lower level of antithrombin
immediately after arrival in the emergency
department and during the early stage of trauma.
 Almost all ACOTS patients meet the criteria for a
diagnosis of DIC; therefore, the same changes in the
platelet counts, global markers of coagulation and
fibrinolysis, and antithrombin levels are observed in
patients with DIC and ACOTS.
 The JAAM DIC score obtained immediately after
arrival in the emergency department is an
independent predictor of the need for a massive
transfusion and of death in trauma patients.
Additional file
Additional file 1: The details of the number of patients in Figures 2
and 3.
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